LEADER 01112nam--2200349---450- 001 990002973340203316 005 20090617104944.0 035 $a000297334 035 $aUSA01000297334 035 $a(ALEPH)000297334USA01 035 $a000297334 100 $a20070917d1937----km-y0itay0103----ba 101 0 $aita 102 $aIT 105 $a||||||||001yy 200 1 $aCompendio di Storia$eed elementi di diritto e di economia$fFerdinando Albeggiani$eper la maturità classica, scientifica e per l'abilitazione magistrale$econforme ai programmi del 7 maggio 1936 XIV 205 $a2. ed rifatta 210 $aPalermo$cTrimarchi$d[1937] 215 $a241 p.$d20 cm. 606 0 $aStoria$xManuali 676 $a909 700 1$aALBEGGIANI,$bFerdinando$0387846 801 0$aIT$bsalbc$gISBD 912 $a990002973340203316 951 $aFC M 2266$b4976 DLM$cFC M 959 $aBK 969 $aDILAM 979 $aDILAM$b90$c20070917$lUSA01$h1130 979 $aDILAM$b90$c20070917$lUSA01$h1132 979 $aDILAM1$b90$c20090617$lUSA01$h1049 996 $aCompendio di Storia$91027691 997 $aUNISA LEADER 01279nam--2200385---450- 001 990002040500203316 005 20040930134142.0 035 $a000204050 035 $aUSA01000204050 035 $a(ALEPH)000204050USA01 035 $a000204050 100 $a20040930d1977----km-y0itay0103----ba 101 0 $ager 102 $aDE 105 $a||||||||001yy 200 1 $aMacht und Armut$eeine theoretisch-empirische untersuchung$fvon Peter Bachrach, Morton S. Baratz$geinleitung von Claus Offe$gaus dem amerikanischen von Manfred Tauscher und Holger Fliessbach 210 $aFrankfurt am Main$cSuhrkamp$d1977 215 $a264 p.$d18 cm 225 2 $aEdition Suhrkamp$v813 410 0$12001$aEdition Suhrkamp$v813 454 1$12001$aPower and poverty : theory and practice$938937 461 1$1001-------$12001 700 1$aBACHRACH,$bPeter$0128541 701 1$aBARATZ,$bMorton S.$0233893 702 1$aOFFE,$bClaus 702 1$aTAUSCHER,$bManfred 702 1$aFLIESSBACH,$bHolger 801 0$aIT$bsalbc$gISBD 912 $a990002040500203316 951 $aCOLL SV 813$b11281 E.C.$cCOLL SV 813 959 $aBK 969 $aGIU 979 $aSIAVPROV$b10$c20040930$lUSA01$h1341 996 $aPower and poverty : theory and practice$938937 997 $aUNISA LEADER 04137nam 22007695 450 001 9910728396903321 005 20251008144934.0 010 $a9783031295416$b(electronic bk.) 010 $z9783031295409 024 7 $a10.1007/978-3-031-29541-6 035 $a(MiAaPQ)EBC30552979 035 $a(Au-PeEL)EBL30552979 035 $a(OCoLC)1380875404 035 $a(DE-He213)978-3-031-29541-6 035 $a(BIP)089067678 035 $a(PPN)270616381 035 $a(CKB)26784778600041 035 $a(EXLCZ)9926784778600041 100 $a20230526d2023 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aAdvances in Pharmacokinetics and Pharmacodynamics /$fedited by Panos Macheras 205 $a1st ed. 2023. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2023. 215 $a1 online resource (208 pages) 225 1 $aAAPS Introductions in the Pharmaceutical Sciences,$x2522-8358 ;$v9 311 08$aPrint version: Macheras, Panos Advances in Pharmacokinetics and Pharmacodynamics Cham : Springer International Publishing AG,c2023 9783031295409 327 $aPharmacokinetics -- Chapter 1: Current status in PBPK modeling -- Chapter 2: Physiologically based biopharmaceutics modeling (PBBM) Application on Food Effect Assessment -- Chapter 3: Physiologically based finite time pharmacokinetic (PBFTPK) models: Inception and development -- Chapter 4: Physiologically based finite time pharmacokinetic (PBFTPK) models: Applications -- Pharmacodynamics -- Chapter 5: Pharmacokinetic ? Pharmacodynamic Modelling and Simulation in Clinical Practice and Studies -- Chapter 6: On the Verge of Impossibility: Accounting for Variability Arising from Permutations of Comorbidities that Affect the Fate of Drugs in the Human Body -- Chapter 7: Impact of Clinical Pharmacology on the Modernization of Drug Development and Regulation. 330 $aThis book provides a concise overview of recent advances in Pharmacokinetics (PK) and Pharmacodynamics (PD). The pharmacokinetics section covers the state of the art in Physiologically Based Pharmacokinetic (PBPK) modeling (Chapter 1) as well as the assessment of food effect on drug absorption using PBPK modeling (Chapter 2). Chapters 3 and 4 describe the recent development of Physiologically Based Finite Time Pharmacokinetic (PBFTPK) models and their applications to pharmacokinetic data. The pharmacodynamics section focuses on PK/PD modeling. Chapter 5 provides an overview of PK/PD modeling and simulation in clinical practice and studies. Chapter 6 deals with the subject/physiology variability issue encountered in PK/PD studies, while Chapter 7 reviews the influence of clinical pharmacology in the modernization of drug development and regulation. This book is an essential reference for pharmaceutical scientists. 410 0$aAAPS Introductions in the Pharmaceutical Sciences,$x2522-8358 ;$v9 606 $aDrug delivery systems 606 $aDrugs$xDesign 606 $aPharmaceutical chemistry 606 $aMetabolism 606 $aPharmacology 606 $aClinical biochemistry 606 $aDrug Delivery 606 $aStructure-Based Drug Design 606 $aPharmaceutics 606 $aMetabolism 606 $aPharmacology 606 $aMedical Biochemistry 615 0$aDrug delivery systems. 615 0$aDrugs$xDesign. 615 0$aPharmaceutical chemistry. 615 0$aMetabolism. 615 0$aPharmacology. 615 0$aClinical biochemistry. 615 14$aDrug Delivery. 615 24$aStructure-Based Drug Design. 615 24$aPharmaceutics. 615 24$aMetabolism. 615 24$aPharmacology. 615 24$aMedical Biochemistry. 676 $a615.7 676 $a615.7 700 $aMacheras$b P$g(Panos)$01351088 702 $aMacheras$b P$g(Panos),$4oth 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 912 $a9910728396903321 996 $aAdvances in Pharmacokinetics and Pharmacodynamics$94467070 997 $aUNINA